Issue of Equity and Related Party Transaction

Issue of Equity and Related Party Transaction

SkinBioTherapeutics plc (AIM: SBTX) ("SkinBioTherapeutics" or the "Company"), a life sciences company focused on skin health, announces that it has raised a total of £1,500,000 via a placing of 9,375,000 new ordinary shares ("Placing Shares") at a price of 16 penc...

18th February, 2019 Read More

Half year results

Half year results

Manchester, UK - 14 February 2019 - SkinBioTherapeutics plc (AIM: SBTX or the "Company") a life sciences company focused on skin health, has announced its half year results for the six months to 31 December 2018....

14th February, 2019 Read More

Interim update on human studies and extension of IP portfolio

Interim update on human studies and extension of IP portfolio

Manchester, UK - 31 January 2019 - SkinBioTherapeutics plc (AIM: SBTX - "SkinBioTherapeutics" or the "Company"), a life science company focused on skin health, provides interim data on the third and final phase of its human studies and an update on one of its patents....

31st January, 2019 Read More

Business review

Business review

CEO, Prof Cath O'Neill provides a review on 2018 and outlook for the key aspects of 2019. ...

14th December, 2018 Read More

Commencement of final phase of human studies

Commencement of final phase of human studies

Manchester, UK - 20 November 2018 - SkinBioTherapeutics plc (AIM: SBTX - "SkinBioTherapeutics" or the "Company"), a life science company focused on skin health, announces the commencement of the third and final phases of its human study and provides a summary of key scientific a...

20th November, 2018 Read More

SkinBiotix® technology generates positive data in first two elements of its human study

SkinBiotix® technology generates positive data in first two elements of its human study

Manchester, UK - 7 November 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, announces positive data from the first two elements of its human study which focus on skin irritancy and moisturisation potential....

7th November, 2018 Read More
investors logo